Effects of Lutein Supplementation on Subclinical Atherosclerosis

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT01534533

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01534533
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01534533. Randomized; quadruple masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2011-06 (actual). Results posted on 2012-10-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Lutein Supplementation on Subclinical Atherosclerosis
Condition
Carotid Atherosclerosis
Condition
Carotid Intimal Medial Thickness 1
Intervention (Dietary supplement)
Placebo
Intervention (Dietary supplement)
Lutein group
Intervention (Dietary supplement)
Combination group
Intervention (Dietary supplement)
Normal lutein control group
Lead sponsor
Peking University (class: other)

Record details

Record id
cardio:ct-nct01534533
Content hash
00aa42f76fa2b4be01d9c0804504357c0d1344104c585ad70a4f9ed83be6b033